404
Protein Engineering Market Analysis & Forecast | 2022-2028
Protein Engineering Market Size, Share, Trend, Forecast, Industry Analysis & Growth Opportunity– 2022-2028
Protein Engineering Market is Segmented by Products & Services Type (Instruments, Consumables, and Software & Services), by Protein Type (Monoclonal Antibodies, Erythropoietin, Interferons, Vaccines, Colony-Stimulating Factors, Growth Hormones, Coagulation Factors, and Others), by Technology...
The market was valued at USD 2.6 billion in 2021.
The market is likely to reach USD 5.96 Billion in 2028.
The projected CAGR for the market will be 12.49%.
Bio-Rad Laboratories, Inc., Thermo Fisher Scientific, Inc., Bruker Corporation, Agilent Technologies, Inc., Waters Corporation, Danaher Corporation, Codexis, Inc., New England Biolabs, Inc., PerkinElmer, Innovagen AB, GE Healthcare, CUSABIO TECHNOLOGY LLC, Promega Corporation, Merck KGaA, GenScript Biotech Corporation, Takara Bio, Inc., Enantis S.R.O., InvivoGen, Pace Analytical, Aspira Chemical, Zymeworks, Inc., Abzena, Ltd., PhyNexus, Inc., ProteoGenix, and Creative Biolabs.
Protein engineering is the process of altering a protein sequence to attain the desired result such as increased stability to the temperature, organic solvents, and/or extremes of pH or a change in the substrate capacity.
North America is expected to be the leading region in the market during the next five years.
The monoclonal antibodies and instrument segment are expected to be the most dominant segment in the market.
Some of the major factors driving the market are Increasing investments in synthetic biology and mounting focus on protein-based drug development by biotechnology and pharmaceutical companies.